Makretskaya et al. demonstrated a heterozygous variant of NKX2-5 c.G676A of unknown pathogenicity and significance in a patient with thyroid hypoplasia and CH [14]. This evidence concerns the gene NKX2-5 and thyroid hypoplasia.